ALLMedicine™ Acneiform Eruptions Center
Research & Reviews 50 results
https://doi.org/10.1007/s00520-022-07257-2 10.1517/14728222.2011.648617 10.1159/000371821 10.1677/erc.1.00600 10.1097/CAD.0b013e3283330590 10.1158/1078-0432.CCR-12-1558 10.1158/1535-7163.MCT-12-0195 10.1158/2159-8290.CD-17-1226 10.1093/annonc/mdx040 10.1007/s00520-020-05381-5 10.1007/s11912-013-0308-6 10.1016/j.jaad.2006.09.005 10.3747/co.22.2430 10.4103/0019-5154.131398 10.1007/s00520-012-1623-4 10.1111/ajd.12124 10.1634/theoncologist.12-5-610 10.1002/cncr.23621 10.1007/s00520-011-1197-6 10.6004/jnccn.2009.0074 10.1007/s40257-018-0384-3 10.1056/NEJMoa050753 10.1007/s00520-016-3419-4 10.1007/s40487-017-0050-6 10.1016/j.jaad.2019.10.003 10.1111/j.1365-2133.2005.06835.x 10.2340/00015555-0330 10.1097/JTO.0b013e3181ec1729
Supportive Care in Cancer : Official Journal of the Multi... Ibraheim MK, Lo J et. al.
Jul 1st, 2022 - Epidermal growth factor receptor inhibitors (EGFRI) can be used with pathway inhibitors, including mitogen-activated protein kinase kinase inhibitors (MEKIs), BRAF inhibitors (BRAFIs), and checkpoint inhibitors such as programmed death-ligand 1 (P...
https://emedicine.medscape.com/article/1072815-overview
Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...
https://emedicine.medscape.com/article/1072815-print
Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...
http://emedicine.medscape.com/article/1072815-overview
Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...
https://emedicine.medscape.com/article/1072815-
Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...
Drugs 4 results see all →
Clinicaltrials.gov 2 results
https://clinicaltrials.gov/ct2/show/NCT02774590
Nov 11th, 2021 - Rosacea affects roughly 16 million Americans who desire better treatments than those currently available. Acne vulgaris, another chronic inflammatory skin disorder, mainly affects teenagers but also affects 20-40% of adults. Investigating potentia...
https://clinicaltrials.gov/ct2/show/NCT04864717
Sep 8th, 2021 - Background and Study Aims: Tyrosine Kinase inhibitors (TKIs) have become standard of care in patients with EGFR mutations in non-small cell lung cancer and other EGFR-mutated cancers. However, TKIs are well-known to cause cutaneous adverse events,...
News 15 results
https://www.medscape.com/viewarticle/975030
Jun 3rd, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Acneiform eruptions in patients with colorectal cancer are more extensive and severe when targeted cancer therapie...
https://www.onclive.com/view/strategies-to-minimize-mtor-related-dermatologic-adverse-events
Dec 5th, 2020 - Mario E. Lacouture, MD Many patients being treated with mTOR inhibitors experience dermatologic-related adverse events. Dermatologic side effects can have a psychosocial effect on patients, by affecting areas of the body exposed to other peop...
https://www.medscape.com/viewarticle/934675
Jul 30th, 2020 - NEW YORK (Reuters Health) - Skin reactions are common in youngsters on MEKI/BRAFI therapy, often resulting in alterations or interruptions in cancer therapy, according to a multicenter retrospective study. "Every child in our study developed at le...
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor
Josh A. Hammel, MD, Dean Elhag, MD et. al.
Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.
https://www.medpagetoday.com/dermatology/generaldermatology/84180
Jan 2nd, 2020 - A repurposed cancer drug shows promise for the treatment of a rare but disabling non-malignant disease in children that is characterized by palmoplantar keratoderma (PPK) and periorificial hyperkeratotic plaques, two case series indicated. In the ...
